Cargando…
Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033429/ https://www.ncbi.nlm.nih.gov/pubmed/27774236 http://dx.doi.org/10.1093/jlb/lsv060 |
| _version_ | 1782455143290109952 |
|---|---|
| author | Herder, Matthew |
| author_facet | Herder, Matthew |
| author_sort | Herder, Matthew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5033429 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50334292016-10-21 Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada Herder, Matthew J Law Biosci Peer Commentary Oxford University Press 2016-01-07 /pmc/articles/PMC5033429/ /pubmed/27774236 http://dx.doi.org/10.1093/jlb/lsv060 Text en © The Author 2016. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Peer Commentary Herder, Matthew Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title | Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title_full | Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title_fullStr | Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title_full_unstemmed | Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title_short | Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada |
| title_sort | orphan drug incentives in the pharmacogenomic context: policy responses in the usa and canada |
| topic | Peer Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033429/ https://www.ncbi.nlm.nih.gov/pubmed/27774236 http://dx.doi.org/10.1093/jlb/lsv060 |
| work_keys_str_mv | AT herdermatthew orphandrugincentivesinthepharmacogenomiccontextpolicyresponsesintheusaandcanada |